IPI-926 Extension Protocol for Continuation of Treatment With IPI-926
Clinical trial NCT01609179 · COMPLETED
Trial details
- NCT number
- NCT01609179
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.